Olink Launches PLA-Based Plasma Protein Biomarker-Discovery Service
March 11, 2011
Olink Launches PLA-Based Plasma Protein Biomarker-Discovery Service
The service, which features a panel of 74 potential cancer protein biomarkers, uses the company's real-time PCR-based proximity ligation assay-based immunoassay platform to detect markers in plasma volumes as small as 2 microliters.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Expanded Proximity Ligation Assay Could Prove Valuable for Biomarker Studies, Top-Down Proteomics
May 13, 2011 / ProteoMonitor - Yale Researcher Suggests More Focus on EGFR Isoforms Needed in Development of Antibody-Based Drugs
May 20, 2011 / ProteoMonitor - Some Proteomics Firms Exploring Next-Generation Sequencing for Biomarker Research
May 6, 2011 / ProteoMonitor - Myriad to Enter Proteomics Market with $80M Purchase of Rules-Based Medicine
April 29, 2011 / ProteoMonitor - NextGen Launches Protein Biomarker Discovery Panel; Aims to Take Market Share from RBM
March 18, 2011 / ProteoMonitor